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Histoplasma capsulatum in the bone marrow of an HIV-infected patient
Figure 1. Histoplasma capsulatum within histiocytes seen on bone marrow biopsy staining: (A) Wright–Giemsa, (B) Giemsa, (C) periodic acid–Schiff, and (D) Gomori–Grocott.
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journal homepage: www.elsevier .com/ locate / i j idA 41-year-old man was admitted to the emergency department
with a 1-month history of weight loss, intermittent fever, and
malaise. Generalized pallor, mild dehydration, and a temperature
of 37.5 C were found on physical examination. Initial blood
workup revealed pancytopenia, elevated lactate dehydrogenase,
and hypoalbuminemia. A fourth-generation HIV ELISA test was
positive. His HIV-1 RNA viral load was 13 800 copies/ml and the
CD4+ T-cell count was 3 cells/mm3. Urine, blood, and cerebrospinal
fluid cultures were without microbiological isolation.
Histopathological analysis of the bone marrow revealed
oval-shaped yeast cells within histiocytes, some showing
narrow-based budding (Figure 1). Histoplasma urine antigen
was >25 ng/ml (normal limit <0.5 ng/ml). The diagnosis ofhttp://dx.doi.org/10.1016/j.ijid.2017.06.018
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For personal use only. No other uses without permissHistoplasma capsulatum infection was made. Antifungal therapy
with amphotericin B deoxycholate was administered for a 14-day
period. Given the successful clinical response, therapy was
switched to oral itraconazole 200 mg every 8 h for 3 days. The
patient was subsequently discharged with itraconazole 200 mg
every 12 h indefinitely. Highly active antiretroviral therapy was
started a week later following an appointment at an HIV outpatient
clinic.
The detection of H. capsulatum polysaccharide antigen in HIV-
infected patients has a 95–100% sensitivity in urine and 92–100%
sensitivity in serum (Connolly et al., 2007). False-positive antigen
tests have been reported in cases of Penicillium marneffei infection,
blastomycosis, and paracoccidioidomycosis (Hage et al., 2011).ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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I. Medina-Piñón et al. / International Journal of Infectious Diseases 62 (2017) 6–7 7Bone marrow aspirate analyzed by an experienced operator can
contribute to the differential diagnosis (Adenis et al., 2014).
Identification by culture is the gold standard, with 85–90%
sensitivity and 100% specificity (Hage et al., 2011; Couppie et al.,
2006). The primary therapy recommended is liposomal ampho-
tericin B; unfortunately its high cost makes it unaffordable in many
developing countries. Amphotericin B deoxycholate is an accessi-
ble treatment option. Oral itraconazole is an alternative oral
treatment option and should be prescribed for a 12-month period,
or until the CD4+ T-cell count is >150 cells/mm3 (Couppie et al.,
2006; Wheat et al., 2007).
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